The bone resorption inhibitors Odanacatib and Alendronate affect post-osteoclastic events differently in Ovariectomized rabbits

Calcified Tissue International

Volumn 94, Issue 2, 2014, Pages 212-222

  Jensen, Pia Rosgaard ^a,c   Andersen, Thomas Levin ^a   Pennypacker, Brenda L ^b   Duong, Le T ^b   Delaissé, Jean Marie ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b MERCK RESEARCH LABORATORIES   (United States)

^c LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Bisphosphonate; Bone formation; Cathepsin K; Coupling of bone resorption and formation; Osteoclast; Reversal phase

Indexed keywords

ALENDRONIC ACID; ESTROGEN; ODANACATIB;

ARTICLE; BONE MINERALIZATION; BONE REMODELING; CELL LINEAGE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOID; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; RABBIT; RIGIDITY;

ALENDRONATE; ANIMALS; BIPHENYL COMPOUNDS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONE RESORPTION; FEMALE; OSTEOCLASTS; OSTEOGENESIS; OVARIECTOMY; RABBITS;

EID: 84892445198     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9800-0     Document Type: Article

References (45)

1. Reid IR (2008) Anti-resorptive therapies for osteoporosis. Semin Cell Dev Biol 19:473-478
2. Lewiecki EM (2011) New targets for intervention in the treatment of postmenopausal osteoporosis. Nat Rev Rheumatol 7:631-638
3. Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW (2006) A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J Bone Miner Res 21:366-373
4. Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, Doellgast G, Gong J, Gao Y, Cao J, Graham K, Tipton B, Cai J, Deshpande R, Zhou L, Hale MD, Lightwood DJ, Henry AJ, Popplewell AG, Moore AR, Robinson MK, Lacey DL, Simonet WS, Paszty C (2010) Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 25:948-959
5. Eisman JA, Bone HG, Hosking DJ, McClung MR, Reid IR, Rizzoli R, Resch H, Verbruggen N, Hustad CM, DaSilva C, Petrovic R, Santora AC, Ince BA, Lombardi A (2011) Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res 26:242-251
6. Masarachia PJ, Pennypacker BL, Pickarski M, Scott KR, Wesolowski GA, Smith SY, Samadfam R, Goetzmann JE, Scott BB, Kimmel DB, Duong LT (2012) Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys. J Bone Miner Res 27:509-523
7. Pennypacker BL, Duong LT, Cusick TE, Masarachia PJ, Gentile MA, Gauthier JY, Black WC, Scott BB, Samadfam R, Smith SY, Kimmel DB (2011) Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits. J Bone Miner Res 26:252-262
8. Leung P, Pickarski M, Zhuo Y, Masarachia PJ, Duong LT (2011) The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone 49:623-635
9. Duong LT (2012) Therapeutic inhibition of cathepsin K - reducing bone resorption while maintaining bone formation. BoneKEy Reports 1:67
10. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse JM (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347-32352
11. Andersen TL, Abdelgawad ME, Kristensen HB, Hauge EM, Rolighed L, Bollerslev J, Kjaersgaard-Andersen P, Delaisse JM (2013) Understanding coupling between bone resorption and formation: are reversal cells the missing link? Am J Pathol 183:235-246
12. Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W (2002) The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17:77-90
13. Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504-513
14. Baron R, Vignery A, Lang R (1981) Reversal phase and osteopenia: defective coupling of resorption to formation in the pathogenesis of osteoporosis. In: Deluca H, Frost H, Jee W, Johnston C, Parfitt A (eds) Osteoporosis: recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 311-320
15. van de Wijngaert FP, Burger EH (1986) Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification. J Histochem Cytochem 34:1317-1323
16. Jensen PR, Andersen TL, Soe K, Hauge EM, Bollerslev J, Amling M, Barvencik F, Delaisse JM (2012) Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: a study of healthy individuals and patients with Cushing's syndrome. J Bone Miner Res 27:770-780
17. Kristensen HB, Andersen TL, Marcussen N, Rolighed L, Delaisse JM (2013) Increased presence of capillaries next to remodeling sites in adult human cancellous bone. J Bone Miner Res 28:574-585
18. Dempster DW, Birchman R, Xu R, Lindsay R, Shen V (1995) Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 16:157-161
19. Sims NA, Morris HA, Moore RJ, Durbridge TC (1996) Increased bone resorption precedes increased bone formation in the ovariectomized rat. Calcif Tissue Int 59:121-127
20. Jayakar RY, Cabal A, Szumiloski J, Sardesai S, Phillips EA, Laib A, Scott BB, Pickarski M, Duong LT, Winkelmann CT, McCracken PJ, Hargreaves R, Hangartner TN, Williams DS (2012) Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: a study with odanacatib treatment in the ovariectomized adult rhesus monkey. Bone 50:1379-1388
21. Cusick T, Chen CM, Pennypacker BL, Pickarski M, Kimmel DB, Scott BB, Duong LT (2012) Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey. J Bone Miner Res 27:524-537
22. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577-2586
23. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ (1997) Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475-1480
24. da Paz LH, de Falco V, Teng NC, dos Reis LM, Pereira RM, Jorgetti V (2001) Effect of 17beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats. Braz J Med Biol Res 34:1015-1022
25. Everts V, Delaisse JM, Korper W, Beertsen W (1998) Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res 13:1420-1430
26. Chappard D, Libouban H, Mindeholm L, Basle MF, Legrand E, Audran M (2010) The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients. Microsc Res Tech 73:726-732
27. Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W (2006) Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res 21:1399-1408
28. Delaisse JM, Boyde A, Maconnachie E, Ali NN, Sear CH, Eeckhout Y, Vaes G, Jones SJ (1987) The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305-313
29. Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T, Yamamura T (1997) Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 272:8109-8112
30. Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK (2001) Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 142:5371-5378
31. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figure K (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453-13458
32. Mano H, Yuasa T, Kameda T, Miyazawa K, Nakamaru Y, Shiokawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M (1996) Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223:637-642
33. Furuyama N, Fujisawa Y (2000) Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts. Steroids 65:371-378
34. Vanderoost J, Soe K, Merrild DM, Delaisse JM, van Lenthe GH (2013) Glucocorticoid-induced changes in the geometry of osteoclast resorption cavities affect trabecular bone stiffness. Calcif Tissue Int 92:240-250
35. Soe K, Merrild DM, Delaisse JM (2013) Steering the osteoclast through the demineralization-collagenolysis balance. Bone 56:191-198
36. Fuller K, Lawrence KM, Ross JL, Grabowska UB, Shiroo M, Samuelsson B, Chambers TJ (2008) Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. Bone 42:200-211
37. Mundy GR, Rodan SB, Majeska RJ, Demartino S, Trimmier C, Martin TJ, Rodan GA (1982) Unidirectional migration of osteosarcoma cells with osteoblast characteristics in response to products of bone resorption. Calcif Tissue Int 34:542-546
38. Tang Y, Wu XW, Lei WQ, Pang LJ, Wan C, Shi ZQ, Zhao L, Nagy TR, Peng XY, Hu JB, Feng X, Van Hul W, Wan M, Cao X (2009) TGF-beta 1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15:757-765
39. Domon T, Suzuki R, Takata K, Yamazaki Y, Takahashi S, Yamamoto T, Wakita M (2001) The nature and function of mononuclear cells on the resorbed surfaces of bone in the reversal phase during remodeling. Ann Anat 183:103-110
40. Bollerslev J, Marks SC, Pockwinse S, Kassem M, Brixen K, Steiniche T, Mosekilde L (1993) Ultrastructural investigations of bone resorptive cells in 2 types of autosomal-dominant osteopetrosis. Bone 14:865-869
41. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A (2000) Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320
42. Schaller S, Henriksen K, Sveigaard C, Heegaard AM, Helix N, Stahlhut M, Ovejero MC, Johansen JV, Solberg H, Andersen TL, Hougaard D, Berryman M, Shiodt CB, Sorensen BH, Lichtenberg J, Christophersen P, Foged NT, Delaisse JM, Engsig MT, Karsdal MA (2004) The chloride channel inhibitor N53736 prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res 19:1144-1153
43. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K (2007) Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22:487-494
44. Andersen TL, Sondergaard TE, Skorzynska KE, Dagnaes-Hansen F, Plesner TL, Hauge EM, Plesner T, Delaisse JM (2009) A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 174:239-247
45. Miller SC, Wronski TJ (1993) Long-term osteopenic changes in cancellous bone structure in ovariectomized rats. Anat Rec 236:433-441